Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection
Cell Host & Microbe · 2023-05 · 31 (5) · 695-711
DOI: 10.1016/j.chom.2023.03.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2023-05. Verfasst von Abbas Yadegar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical …. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Fecal microbiota transplantation (FMT) is highly effective in preventing recurrent Clostridioides difficile infection (rCDI). However, the mechanisms underpinning its clinical efficacy are incompletely understood. Herein, we provide an overview of rCDI pathogenesis followed by a discussion of potential mechanisms of action focusing on the current understanding of trans-kingdom microbial, metabolic, immunological, and epigenetic mechanisms. We then outline the current research gaps and offer methodological recommendations for future studies to elevate the quality of research and advance knowledge translation. By combining interventional trials with multiomics technology and host and environmental factors, analyzing longitudinally collected biospecimens will generate results that can be validated with animal and other models. Collectively, this will confirm causality and improve translation, ultimately to develop targeted therapies to replace FMT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- School of Engineering, University of British Columbia, Kelowna, BC, Canada.
- National Institute for Health Research Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
- Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.
- School of Microbiology, Department of Medicine and APC Microbiome Ireland, University College Cork, Cork, Ireland.
- Department of Biological Sciences, Clemson University, Clemson, SC, USA.
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Yadegar, A., Pakpoor, S., Ibrahim, F. F., Nabavi-Rad, A., Cook, L., Walter, J., Seekatz, A. M., Wong, K., Monaghan, T. M., & Kao, D. (2023). Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection. Cell Host & Microbe, 31(5), 695-711. https://doi.org/10.1016/j.chom.2023.03.019
Vancouver
Yadegar A, Pakpoor S, Ibrahim FF, Nabavi-Rad A, Cook L, Walter J, et al. Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection. Cell Host & Microbe. 2023;31(5):695-711. doi:10.1016/j.chom.2023.03.019
BibTeX
@article{Yadegar2023,
author = {Yadegar, Abbas and Pakpoor, Sepideh and Ibrahim, Fathima F and Nabavi-Rad, Ali and Cook, Laura and Walter, Jens and Seekatz, Anna M and Wong, Karen and Monaghan, Tanya M and Kao, Dina},
title = {Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection},
journal = {Cell Host & Microbe},
year = {2023},
volume = {31},
number = {5},
pages = {695--711},
doi = {10.1016/j.chom.2023.03.019}
}
EUVIMED